Delivery Order SPE2DR25D3501-SPE2DR26FL8TT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,425.04 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The contract was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, under firm fixed pricing with no set-aside designation. Performance of this delivery order will occur at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml, a human growth hormone medication, valued at $5,005.52 with a firm fixed price structure. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,010.60 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.32 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication, with delivery expected by October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,360.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 ml pharmaceutical products, with an ultimate completion date of November 10, 2025. This non-set-aside competitive award was issued on November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $1,764.09 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication used to treat growth disorders and related conditions. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL8TTDelivery Order
The Defense Logistics Agency awarded a $2,208.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone treatment. The contract, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Norditropin reflects AmerisourceBergen's ongoing role in providing essential medications to support defense health requirements through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/14/25 |